Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Cardiac Rehabilitation Devices Market

ID: MRFR/MED/12091-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Cardiac Rehabilitation Devices Market Research Report By Device Type (Elliptical Trainer, Rower, Blood Pressure Monitor, Treadmill, Stabilization Ball, Heart Rate Monitor), By End User (Rehab Centers, Research Centers, Specialty Centers, Hospitals, Clinics), By Patient Type (Percutaneous Coronary Intervention, Myocardial Ischemia, Coronary Artery Bypass Grafting, Coronary Artery Disease) and By Phase (Phase I, Phase II, Phase III) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Device Type (USD Million)
      1. 4.1.1 Elliptical Trainer
      2. 4.1.2 Rower
      3. 4.1.3 Blood Pressure Monitor
      4. 4.1.4 Treadmill
      5. 4.1.5 Stabilization Ball
      6. 4.1.6 Heart Rate Monitor
    2. 4.2 Medical Device, BY End User (USD Million)
      1. 4.2.1 Rehab Centers
      2. 4.2.2 Research Centers
      3. 4.2.3 Specialty Centers
      4. 4.2.4 Hospitals
      5. 4.2.5 Clinics
    3. 4.3 Medical Device, BY Patient Type (USD Million)
      1. 4.3.1 Percutaneous Coronary Intervention
      2. 4.3.2 Myocardial Ischemia
      3. 4.3.3 Coronary Artery Bypass Grafting
      4. 4.3.4 Coronary Artery Disease
    4. 4.4 Medical Device, BY Phase (USD Million)
      1. 4.4.1 Phase I
      2. 4.4.2 Phase II
      3. 4.4.3 Phase III
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Philips (NL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Abbott (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Bayer (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 GE Healthcare (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Johnson & Johnson (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Siemens Healthineers (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Cardinal Health (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DEVICE TYPE
    3. 6.3 US MARKET ANALYSIS BY END USER
    4. 6.4 US MARKET ANALYSIS BY PATIENT TYPE
    5. 6.5 US MARKET ANALYSIS BY PHASE
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY DEVICE TYPE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY PATIENT TYPE, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY PHASE, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY PHASE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY END USER, 2025-2035 (USD Million)
      3. 7.2.3 BY PATIENT TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY PHASE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Medical Device Market Segmentation

Medical Device By Device Type (USD Million, 2025-2035)

  • Elliptical Trainer
  • Rower
  • Blood Pressure Monitor
  • Treadmill
  • Stabilization Ball
  • Heart Rate Monitor

Medical Device By End User (USD Million, 2025-2035)

  • Rehab Centers
  • Research Centers
  • Specialty Centers
  • Hospitals
  • Clinics

Medical Device By Patient Type (USD Million, 2025-2035)

  • Percutaneous Coronary Intervention
  • Myocardial Ischemia
  • Coronary Artery Bypass Grafting
  • Coronary Artery Disease

Medical Device By Phase (USD Million, 2025-2035)

  • Phase I
  • Phase II
  • Phase III